Patheon Places Big Bet with Mova Acquisition

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-01-02-2005
Volume 29
Issue 1

Patheon is betting the whole is worth more than the sum of the parts in its acquisition of Puerto Rico contract manufacturer Mova.

External Link - article-141816.pdf

Articles in this issue
An Overview of the Effect of Moisture on Compaction and Compression
Method Development of Swab Sampling for Cleaning Validation of a Residual Active Pharmaceutical Ingredient
The Pipeline Crisis
The Outsourcing Advantages in Formulation Development
Drug Safety and Access Top Policy Concerns for 2005
Comparison of EP "Heavy Metals" Test with USP "Conductivity" Test
Patheon Places Big Bet with Mova Acquisition
Superdisintegrants for Solid Dispersion To Produce Rapidly Disintegrating Tenoxicam Tablets via Camphor Sublimation
January 2005
In the Spotlight-January 2005
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Drug Digest: Strategic Partnerships
Henny Zijlstra from Adragos Pharma chats about the trends affecting the outsourcing market, various strategies being employed by service providers, and the value of end-to-end services.
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Related Content
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com

CN Bio Forms Strategic Partnership with Pharmaron to Develop OOC Technologies

Feliza Mirasol
April 25th 2025
Article

Under the partnership, Pharmaron will validate and promote the application of CN Bio’s PhysioMimix technology and will integrate OOC technologies into its R&D platform.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Paige, Sonrai Form Partnership to Harness AI for Precision Medicine R&D

Patrick Lavery
April 21st 2025
Article
Drug Solutions Podcast: Examining the State of Biopharma Investment

Drug Solutions Podcast: Examining the State of Biopharma Investment

Grant Playter
June 6th 2023
Podcast

In this episode, Siegfried Schmitt, vice president, Technical at Parexel, discusses the state of biopharma investment in 2023.

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Alicia Bigica
April 16th 2025
Article

On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Agentic AI Growth Predicted, but More Than Half of Pharma Still Resisting Change: Report

Patrick Lavery
April 8th 2025
Article

Lack of skills in the AI realm was a distant second among those surveyed about the biggest barrier to innovation while using the technology.